A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (bix study)

Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, Kentaro Yamazaki, Takashi Ura, Takako Nakajima, Ayumu Goto, Ken Shimada, Norisuke Nakayama, Junichi Sakamoto, Satoshi Morita, Yasuhide Yamada

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (bix study)'. Together they form a unique fingerprint.

Medicine & Life Sciences